Cardiac Tests & Procedures Explained

Left Ventricular Hypertrophy (LVH) on Your ECG

August 3, 2026

LVH on Your ECG: What Left Ventricular Hypertrophy Means

Key Points

“Left ventricular hypertrophy” on an ECG report means the tracing showed larger than usual electrical voltages, which can happen when the heart’s main pumping chamber has thickened. It is a suggestion, not a diagnosis.
The ECG measures electrical voltage rather than muscle thickness. It picks up a great deal well, but wall thickness is inferred rather than measured, so a normal ECG does not rule thickening out.
Body build affects the reading. Where there is less tissue between the heart and the electrodes, the voltages run higher with no thickening at all.
An echocardiogram settles the question, because it measures the muscle directly rather than inferring it from voltage.
Where genuine thickening is confirmed, the cause matters more than the finding. High blood pressure is by far the most common, and the thickening can partly reverse when the pressure is treated.

Among the phrases that automated ECG software generates, “left ventricular hypertrophy” is one of the more alarming to read. It sounds like a diagnosis of something structural and permanent. Hypertrophy means enlargement. Left ventricular means the main pumping chamber. Put together, it reads as though a machine has just told you your heart is abnormally big.

What the machine has actually done is add up some voltages and compare the total against a threshold. Whether that reflects anything real about your heart is a separate question, and one the ECG is not well equipped to answer.

What the Left Ventricle Does and Why It Thickens

The left ventricle is the chamber that pushes blood out to the entire body. It is the thickest-walled part of the heart because it does the most work.

Like any muscle, it responds to sustained extra load by getting thicker. If it has to push against higher pressure with every single beat, year after year, the wall builds up in response. That is left ventricular hypertrophy.

It is not a disease in itself. It is an adaptation, and the important question is always what it is adapting to.

What the ECG Can and Cannot Tell You

The ECG is a genuinely valuable test, and it is ordered as often as it is for good reason. It detects rhythm disturbances, conduction problems, and the changes of a heart attack quickly, cheaply and reliably. For those questions it is hard to better.

Wall thickness is simply not one of the things it measures directly. It measures electrical voltage at the skin. The reasoning behind the criteria is that a thicker muscle generates a larger electrical signal, so an unusually large signal might indicate a thicker wall.

That reasoning is sound, but voltage is an indirect measure. Depending on which criteria are used and which population is studied, the ECG identifies somewhere between roughly a fifth and a half of people who genuinely have a thickened left ventricle on imaging. It is a screening signal rather than a measurement.

The reason is that voltage at the skin depends on a great deal besides the heart. Chest wall thickness, body size, lung volume, the position of the heart in the chest, and even the exact placement of the electrodes all influence the reading.

A thicker muscle and a thinner chest wall both raise the voltage, which is why the ECG raises the question rather than answering it.

This is why the finding turns up so often in people whose hearts are entirely normal. Where there is less tissue between the heart and the electrodes, the signal arrives stronger and the voltages read higher. Regular endurance training adds to this, partly for the same reason and partly because it produces some genuine and entirely healthy adaptation of the muscle.

The reverse happens too. Someone carrying extra weight, or with lung disease, may have a genuinely thickened ventricle and a completely unremarkable ECG, because the signal is dampened before it reaches the skin. This is why a normal tracing does not settle the question either.

Two ECG tracings compared. In the first the spikes are of usual height. In the second they are markedly taller, which is what an automated report means by voltage criteria for left ventricular hypertrophy — A thicker muscle can produce a larger signal, so the spikes look taller. A thin chest wall can do the same, which is why the finding prompts a closer look rather than settling the question, Heart Matters

What the Report Might Say

The wording varies between machines, and the differences carry meaning.

“Voltage criteria for LVH” is the mildest version. It means only that the numbers exceeded a threshold. In someone with no symptoms and nothing else on the tracing, this on its own very often means nothing.

“LVH with repolarisation abnormality”, sometimes written as a strain pattern, is a more meaningful finding. Here the tracing shows not just large voltages but changes in how the heart muscle recovers between beats. That combination is more likely to reflect genuine thickening and is more strongly linked to cardiovascular risk over time.

“Left atrial enlargement” appearing alongside it adds weight too, because the upper chamber often enlarges in response to a stiff, thickened ventricle below it.

What Causes Genuine Thickening

High blood pressure is by far the most common cause and the reason the finding matters. Every beat against elevated pressure asks more of the muscle, and the wall thickens accordingly. This is often the first hint that blood pressure has been higher than realised for longer than realised.

Aortic stenosis, where the valve at the exit of the left ventricle narrows, creates the same problem more acutely. The chamber has to force blood through a restricted opening, and thickens in response. Aortic stenosis is usually audible as a murmur, so it rarely comes as a surprise on an ECG alone.

Athletic training produces genuine adaptation in endurance and strength athletes, and it is generally benign and reversible with detraining. Distinguishing it from the conditions below is one of the more nuanced judgements in cardiology.

Hypertrophic cardiomyopathy is an inherited condition in which the muscle thickens without any load driving it. It is much less common than the causes above, but it matters because it can affect young people and runs in families. HCM is one reason an unexplained finding in a young person is worth following up rather than dismissing.

Infiltrative conditions such as cardiac amyloidosis can thicken the wall with deposited protein rather than muscle. A distinctive combination sometimes appears here: a wall that looks thick on imaging alongside unexpectedly small voltages on the ECG.

What Happens Next

The finding is usually followed by an echocardiogram, an ultrasound that measures the wall thickness directly and calculates the muscle mass. It answers in twenty minutes what the ECG could only infer, and it also shows whether the chamber is pumping and filling normally.

Watch: what an echocardiogram involves, what it measures, and why it answers questions the ECG can only raise, Heart Matters Educational Series

Blood pressure assessment usually follows too, and often means readings taken at home or over 24 hours rather than a single clinic measurement, since a one-off reading is a poor guide to the pressure the heart has actually been working against.

Where thickening is confirmed and the cause is not obvious, further tests may follow depending on the pattern seen, which might include cardiac MRI, blood tests, or a family history and genetic assessment if an inherited condition is suspected.

Why It Is Worth Knowing About

Confirmed left ventricular hypertrophy is not something to panic about, but it is not nothing either. It is associated over the long term with a higher likelihood of atrial fibrillation, of heart failure, and of stroke, which is why cardiologists take it seriously as a marker even when the person feels entirely well.

The encouraging part is that it is not necessarily permanent. Where high blood pressure is the cause, sustained treatment can produce measurable regression of the thickening over months to years. The muscle that built up in response to pressure can partly unbuild when the pressure comes down. Studies have found that people whose ECG signs of hypertrophy regress with treatment go on to have fewer cardiovascular events than those whose do not.

That makes this one of the more actionable findings on an ECG report. It points at something that can be changed.

Conclusion

“Left ventricular hypertrophy” on an automated ECG report is a prompt to look further, not a verdict. In someone with no symptoms and an otherwise normal tracing it very often reflects nothing more than how the signal reaches the skin. In someone with high blood pressure it may be the first visible sign of what that pressure has been doing quietly for years.

Either way, the next step is the test that measures the muscle directly. An echocardiogram does that, and it is straightforward. What matters most is the conversation about what might be driving it, because for the most common cause, treatment does not just stop the thickening progressing. It can reverse some of it.

The Stress Echocardiogram: What to Expect

June 29, 2026

A stress echocardiogram combines an ultrasound of the heart with an exercise challenge, revealing how the heart performs under pressure, not just at rest.

ApoB Explained: What It Measures and Why LDL Still Matters

June 24, 2026

Key Points

ApoB is a single protein that sits on the surface of every cholesterol particle capable of causing plaque, so an apoB result is effectively a headcount of all the particles that can harm your arteries.
A standard LDL cholesterol result measures the cholesterol carried inside your particles, not how many particles there are. Most of the time the two agree, but in some people they do not.
When LDL cholesterol looks reassuring but apoB is high, this mismatch (called discordance) can reveal hidden risk that a routine cholesterol panel misses.
Strong evidence supports apoB as an accurate marker of cardiovascular risk, particularly in people with high triglycerides, type 2 diabetes, or metabolic syndrome.
ApoB does not replace your LDL, triglycerides, or lipoprotein(a) results. Each tells you something the others cannot, and the best assessment uses them together.
No single number captures your risk. Heart disease is multifactorial, so blood pressure, diabetes, smoking, weight, and family history all matter alongside your lipids. Investigations such as a calcium score add another layer, and whether to add apoB is a conversation worth having with your cardiologist.

There is a lively and sometimes heated debate online about cholesterol. One vocal group argues that the LDL cholesterol number most of us have measured for decades is almost beside the point, and that a different number, apolipoprotein B, or apoB, is the one that truly predicts heart disease. If you have come across this argument and felt unsure who to believe, you are not alone.

The truth, as is so often the case in medicine, sits between the two extremes. ApoB is a genuinely valuable measurement, and the science behind it is sound. It is also not a magic number that makes everything else obsolete. This article explains what apoB actually is, why it can outperform a standard cholesterol result, and how to think about whether it belongs in your own blood tests.

What Is ApoB, Exactly?

To understand apoB, it helps to picture how cholesterol travels through your blood. Cholesterol is a fatty substance, and fat does not dissolve in water. So your body packages cholesterol inside tiny spherical particles that can move through the bloodstream. The particles that drive atherosclerosis, the gradual furring of the arteries, include LDL (low density lipoprotein) and a few close relatives.

Here is the key fact. Every one of these harmful particles carries exactly one molecule of a protein called apolipoprotein B on its surface. One particle, one apoB. This includes LDL, VLDL, IDL, and even lipoprotein(a). So when a laboratory measures your apoB level, it is effectively counting the total number of particles in your blood that are capable of lodging in your artery wall and forming plaque.

Why Counting Particles Can Beat Measuring Cholesterol

A standard lipid panel reports your LDL cholesterol, which sounds like it should tell you everything. But LDL cholesterol measures the amount of cholesterol carried inside your LDL particles. It does not measure how many particles you have.

This distinction matters because particles vary in size. Some people carry a smaller number of large, cholesterol-rich particles. Others carry a large number of small, cholesterol-poor particles. Two people can have an identical LDL cholesterol result while one has far more circulating particles than the other. Since it is the particles themselves that burrow into the artery wall, the person with more particles carries more risk, even though their cholesterol number looks the same.

A useful way to picture it: imagine traffic on a motorway. LDL cholesterol tells you the total weight of cargo being carried. ApoB tells you how many vehicles are on the road. If your arteries are the road, it is the number of vehicles, not the total cargo, that determines how often something collides with the wall.

One protein per particle

Every harmful cholesterol particle carries a single apoB protein, so your apoB level counts every particle that can cause plaque.

Cargo versus headcount

LDL cholesterol measures the cargo carried inside particles. ApoB counts the particles themselves, which is what damages the artery wall.

Why the gap matters

When particle count is high but cholesterol per particle is low, your LDL result can look fine while your true risk is not.

The family of particles apoB counts

ApoB does not just count LDL. It tags several related particles, each of which can contribute to plaque. This is part of why a single apoB result can be so informative: it captures the whole atherogenic family in one number.

LDL

Low density lipoprotein. The most familiar and most numerous of the harmful particles, and the main driver of plaque in most people.

VLDL and IDL

Larger, triglyceride-rich particles and their remnants. They become more important when triglycerides are high.

Lipoprotein(a)

An LDL-like particle with an extra protein attached. Largely inherited, and counted within apoB but not separately identified by it.

Each of these carries one apoB protein, so they are all captured in your total. What apoB cannot do is tell you the breakdown. It will not reveal, for instance, whether a high count is driven by ordinary LDL or by an inherited excess of Lp(a). That is one reason the individual tests retain their value, a point we return to below.

When LDL Cholesterol and ApoB Disagree

Most of the time, your LDL cholesterol and your apoB tell the same story. When both are high, or both are low, doctors call this concordance, and a standard cholesterol panel serves you perfectly well.

The interesting and clinically important situations are the mismatches, known as discordance. This is when your LDL cholesterol looks acceptable but your apoB is high, signalling many small particles quietly carrying on their work. In this scenario, a reassuring cholesterol result can give false comfort. A large 2024 review of 15 studies involving nearly 600,000 people found that apoB was a more accurate marker of risk than LDL cholesterol in every discordance study examined.

Who is most likely to be discordant

You are more likely to have a meaningful gap between your LDL cholesterol and your apoB if you have any of the following: high triglycerides, type 2 diabetes, metabolic syndrome, central weight gain around the abdomen, or a pattern of small dense LDL particles. People in these groups can have a deceptively normal LDL cholesterol while their particle count, and their risk, runs higher. This is precisely the group in which apoB adds the most.

What the Evidence Actually Shows

The case for apoB is strong, and it is worth being clear about what the research does and does not say.

On the supportive side, apoB has performed consistently well as a predictor of heart attack and stroke, often edging out both LDL cholesterol and non-HDL cholesterol, particularly in people whose results are discordant. Because it counts particles directly, it is less affected by the variations in particle size that can distort a standard cholesterol reading. For people with diabetes or high triglycerides, this advantage is most pronounced.

On the cautious side, this does not mean LDL cholesterol is worthless. Far from it. Lowering LDL cholesterol remains the single most trial-tested intervention in all of preventive cardiology. Decades of randomised trials, including the trials that established statins and newer agents such as PCSK9 inhibitors, were built on LDL cholesterol as the target, and the benefit of lowering it is beyond dispute. The online voices declaring LDL cholesterol irrelevant overstate the case considerably.

Why LDL, Triglycerides, and Lp(a) Still Matter

The enthusiasm for apoB has, in some corners of the internet, tipped into dismissing the numbers we have relied on for years. That is a mistake. Each of the established measurements tells you something apoB alone does not, and a good lipid assessment uses them together.

LDL cholesterol

LDL cholesterol is not a flawed or outdated number. It is the most thoroughly validated treatment target in cardiology, and every major guideline still places it at the centre of care. The reason is simple: when we lower LDL cholesterol in clinical trials, heart attacks and strokes fall in proportion, reliably and repeatedly. ApoB refines how we interpret LDL cholesterol in certain people. It does not unseat it. If you are tracking one number over time to see whether your treatment is working, LDL cholesterol remains an entirely sensible choice.

Triglycerides

Triglycerides are a separate and valuable piece of the puzzle. A raised triglyceride level is one of the clearest signals that your LDL cholesterol and apoB may be discordant, because high triglycerides tend to accompany the small, dense, numerous particles that apoB picks up. Triglycerides also respond strongly to lifestyle, which makes them a useful and motivating number to watch. Diet matters here, and the evidence supporting the Mediterranean diet and omega-3 fats is particularly relevant for people with elevated triglycerides.

Lipoprotein(a)

Lipoprotein(a), or Lp(a), deserves its own place on the test request entirely. It is largely inherited, it changes very little over a lifetime, and a single measurement tells you whether you carry this extra, independent layer of risk. While apoB does count Lp(a) particles among its total, it cannot tell you how much of your risk comes specifically from Lp(a), which is why a dedicated Lp(a) test remains worthwhile in its own right. For many people this is a once-in-a-lifetime measurement that meaningfully changes how aggressively their other risk factors should be managed.

What Does a Statin Do to Your ApoB?

This is a question worth answering directly, because it is one of the most useful things to understand about apoB in practice. Statins lower apoB substantially, typically by somewhere in the range of a quarter to nearly half, broadly in step with how much they lower LDL cholesterol. Adding ezetimibe or a PCSK9 inhibitor brings it down further still. So if you are already on treatment, your apoB is very likely already falling alongside your other numbers.

There is one important exception, and it is the reason apoB does not make the individual tests redundant. Statins do very little to lipoprotein(a). Someone can take a statin, watch their LDL cholesterol and apoB fall nicely, and still carry a high inherited Lp(a) that the treatment has barely touched. This is exactly why measuring Lp(a) at least once, separately, remains worthwhile even for people whose apoB looks well controlled.

ApoB Is One Piece of a Multifactorial Picture

Perhaps the most important point in this whole discussion is the one the online debate tends to forget. Cardiovascular disease is multifactorial. No single number, however good, captures your risk on its own, and apoB is no exception.

Your overall risk is shaped by a web of factors that interact with one another. These include your blood pressure, whether you have type 2 diabetes or features of metabolic syndrome, whether you smoke, your weight and waist measurement, your family history, your level of inflammation, and your age. A person with a perfect apoB but uncontrolled blood pressure and a smoking habit is not low risk. Conversely, a moderately raised apoB carries very different weight in an otherwise healthy 45-year-old than in someone with diabetes and a strong family history.

This is why fixating on any one marker, apoB included, can be misleading. The most useful approach is the one your cardiologist actually uses: weighing your lipids alongside every other modifiable factor. Two of the most powerful of those, smoking and high blood pressure, are entirely separate from your cholesterol particles and yet enormously important. You can read a fuller account in our overview of cardiovascular risk factors.

The Role of Investigations

Blood markers tell you about risk. Imaging can tell you what is actually happening in your arteries, and the two together are far more informative than either alone.

The coronary calcium score is the investigation patients most often ask about, and it can be confusing, so it is worth being clear. A calcium score does not measure your cholesterol or your particle count. It measures calcified plaque that has already formed in your coronary arteries, giving a direct picture of the disease itself rather than the risk factors driving it. A high score can prompt more intensive treatment even when your blood results look reasonable. Our article on what a high calcium score really means explains how to interpret the number.

One genuine source of confusion deserves a mention. Because statins can convert soft plaque into denser, calcified plaque, people on a statin can sometimes see their calcium score rise even as their risk falls. This apparent paradox is explained in our piece on statins and your calcium score. For people who need a more detailed look at the arteries themselves, a CT coronary angiogram can show both calcified and soft plaque. Inflammation markers such as hs-CRP can add yet another dimension. Which of these, if any, is right for you depends entirely on your circumstances and is a decision for you and your cardiologist.

Where the Guidelines Stand

The official guidance reflects this balanced reality. Different expert bodies place apoB at slightly different points on the spectrum, but none has discarded LDL cholesterol.

Guideline body	Position on apoB
European (ESC/EAS)	Accepts apoB as an alternative to LDL cholesterol for risk assessment. The 2025 update still confirms LDL cholesterol as the primary target.
Canadian (CCS)	The most apoB-forward. Allows apoB to be used as the primary therapeutic target, especially when triglycerides are raised.
United States (ACC/AHA)	Lists a high apoB as a risk-enhancing factor that supports more intensive treatment, but does not yet set a routine apoB target.
National Lipid Association	Proposes graded apoB targets that become stricter as cardiovascular risk rises.

The main reason apoB has not yet replaced LDL cholesterol everywhere is not weak evidence. It is the absence of a single agreed target across all guidelines, combined with a degree of caution about changing long-established practice. Availability and cost also vary from one health system to another.

Should You Add ApoB to Your Next Blood Test?

In Australia, apoB can be measured by most pathology laboratories, usually reported in grams per litre. It is not always part of a standard lipid panel and may not be routinely rebated, so it is worth asking whether it applies to your situation and whether there is an out of pocket cost.

There is a strong argument for measuring apoB at least once if you fall into a higher-risk group, particularly if you have raised triglycerides, type 2 diabetes, metabolic syndrome, or a family history of early heart disease. It is also useful when your LDL cholesterol seems well controlled but you or your cardiologist remain concerned about residual risk. For someone already tracking LDL, HDL, and lipoprotein(a), as many thoughtful patients now do, apoB is a natural and informative addition rather than a replacement for any of them.

What apoB cannot do is stand alone. It works best alongside your other blood results, any imaging you have had, and the broader picture of your risk factors. The number is only as useful as the conversation it prompts with the person managing your care.

Heart Matters Resource

When in Doubt, Get Checked Out

If you are unsure whether your cholesterol results tell the full story, a focused review of your numbers with your GP or cardiologist is one of the most worthwhile conversations you can have.

Read: When in Doubt, Get Checked Out →

Conclusion

ApoB is one of the most useful advances in everyday cardiovascular risk assessment, because it counts the particles that actually cause plaque rather than estimating the cholesterol they carry. For people whose standard cholesterol result may be quietly misleading, it can uncover risk that would otherwise go unnoticed.

The balanced takeaway is this. LDL cholesterol, triglycerides, and lipoprotein(a) each remain valuable, and apoB sharpens the picture rather than replacing any of them. None of these numbers stands alone, because heart disease is multifactorial: your blood pressure, diabetes, smoking status, weight, and family history all matter alongside your lipids. The most useful conversation you can have is not about a single number, but about the whole picture, with the cardiologist who knows your circumstances.

What Is a Troponin Test, and Why Is It Used for Chest Pain?

June 19, 2026

Troponin is the blood test at the heart of chest pain assessment. If you have been to emergency with chest pain, here is what it measures and what the result means.

Right Bundle Branch Block (RBBB): Why It Sounds Worse Than It Usually Is

June 15, 2026

Key Points

A right bundle branch block, often shortened to RBBB, is an electrical finding on an ECG. It means the signal travelling to the right side of the heart takes a slightly slower route than usual. It is not a blocked artery.
On its own, in a person who feels well and has a healthy heart, RBBB is common and usually harmless. It is found in roughly 1 in 100 adults, and the figure rises with age.
What matters is the context. A longstanding RBBB in someone with no symptoms is very different from a brand new RBBB that appears alongside chest pain or breathlessness.
RBBB becomes more important when it is new, when it occurs with symptoms, or when it appears together with other electrical changes on the same ECG.
Most people with isolated RBBB need no treatment at all. The block itself is not something that gets fixed, and in the majority of cases it never causes a problem.

Of all the phrases that can appear on an ECG report, “right bundle branch block” is one that sends people straight to a search engine, usually with a rising sense of alarm. The word block sounds ominous. It brings to mind a blocked artery, or something serious going wrong with the heart’s plumbing.

In the great majority of cases, it is neither of those things. This article explains what a right bundle branch block actually is, why it shows up, when it is nothing to worry about, and the smaller number of situations where it genuinely matters.

What the Bundle Branches Actually Do

Your heart has its own electrical wiring. Each beat begins with a signal that spreads across the upper chambers, then passes through a junction box in the centre of the heart and down into the two large lower chambers, the ventricles, which do the heavy pumping work.

From that junction box, the signal travels down two main cables, one to the left ventricle and one to the right. These cables are the bundle branches. They split into ever-finer fibres so that the electrical signal reaches every part of the muscle at almost the same instant, allowing both ventricles to squeeze together in a single coordinated beat.

A right bundle branch block means the cable to the right ventricle is not carrying the signal normally. The impulse is delayed or has to take a detour, reaching the right ventricle a fraction of a second later than it should. The heart still beats. The right ventricle still contracts. It simply gets its instruction by a slightly slower path.

This is quite different from a coronary artery problem, where the issue is blood supply rather than electrical signalling. If you would like to see the wiring for yourself, our interactive guide to your heart’s conduction system shows how the signal travels from the heart’s natural pacemaker down through the bundle branches to the ventricles.

What RBBB Looks Like on an ECG, in Plain Language

An ECG is a recording of the electrical signals that pass through your heart with every beat. Each beat produces a series of waves on the trace, and each wave reflects a different stage of that beat. The first small wave, called the P wave, reflects the upper chambers being activated. The tall central spike, called the QRS, reflects the contraction of the ventricles. The rounded wave that follows, the T wave, reflects those chambers electrically resetting before the next beat.

Because RBBB delays the signal to one ventricle, the two chambers no longer squeeze in perfect unison. The QRS spike, which is normally narrow and sharp, becomes wider and often develops a second bump, giving it a distinctive shape that a cardiologist recognises instantly.

Normal beat

The QRS spike is narrow and sharp. Both ventricles are activated almost together.

Right bundle branch block

The QRS is wider and carries a second bump. This is the delayed right ventricle catching up.

How to read this: the spike in the middle, the QRS, is the part to watch. A normal one is narrow and sharp. In RBBB it is wider and usually has a notch, like an M shape, because the right side of the heart is activated a beat behind the left. The small waves either side are not the focus here.

Why Does a Right Bundle Branch Block Happen?

There are many reasons, and they sit on a wide spectrum from completely benign to clinically important.

A normal variant

In many healthy people, RBBB is simply how their wiring is built. It can be present for life, cause no symptoms, and never lead to any trouble.

Age and the wiring itself

The conduction fibres can slow gradually with age, in the same way other tissues change over time. This is why RBBB becomes more common in later decades.

Strain on the right heart

Conditions that make the right side of the heart work harder, such as some lung conditions, can be associated with RBBB. Here the block is a signpost, not the problem itself.

Heart muscle conditions

Some conditions affecting the heart muscle or its valves can disturb the conduction system and produce RBBB along the way.

After a heart procedure

RBBB can appear after certain cardiac procedures or surgery. When expected, it is usually monitored rather than treated, and most people do well.

A sign during a heart attack

A brand new RBBB that appears during chest pain can be an important warning sign. This is the context that needs urgent assessment, not a routine finding.

The Question That Really Matters: Is It New?

This is the single most useful thing to understand about a right bundle branch block. The pattern itself tells a cardiologist relatively little until it is placed in context, and the most important piece of that context is whether the block is new or longstanding.

A right bundle branch block that has been present on previous ECGs for years, in someone who feels well, is reassuring. It is part of that person’s normal electrical signature. Research consistently shows that isolated RBBB in people without other heart disease carries an excellent outlook.

A right bundle branch block that has appeared for the first time, particularly alongside symptoms such as chest pain, breathlessness, or fainting, is a different matter. Here the new block may be a clue that something is happening in the heart right now, and it deserves prompt evaluation. This is why your cardiologist will often be very interested in finding an old ECG to compare against.

RBBB and LBBB Are Not the Same Story

It is natural to assume that a block on the right and a block on the left are mirror images of each other, equally significant. In practice, they tend to carry different weight.

A left bundle branch block more often prompts a closer look at the heart muscle and its pumping function, because the left ventricle is the heart’s main pump. An isolated right bundle branch block, by contrast, is more frequently a benign finding in an otherwise healthy person.

This is a generalisation rather than a rule, and the context still governs everything. But it helps explain why a patient might be told their RBBB is nothing to worry about while a friend with an LBBB was sent for more tests.

Will I Have Symptoms?

Most people with a right bundle branch block have no symptoms from it whatsoever. They feel completely normal, and the finding is picked up by chance on an ECG done for an unrelated reason, such as a routine check, a pre-operative assessment, or an insurance examination.

Because RBBB itself rarely causes symptoms, any symptoms that are present, such as breathlessness, palpitations, or fainting, usually point to whatever underlying condition is present rather than to the block on its own. That is part of why your cardiologist treats the symptoms and the whole clinical picture, not the line on the ECG report.

What Happens Next, and What Tests Might Be Done

If an isolated RBBB is found and you feel well, often the answer is simply that nothing further is needed beyond noting it on your record. Knowing it is there is valuable in itself, because it gives every future ECG a baseline to compare against.

When the context suggests a closer look is worthwhile, your cardiologist may arrange an echocardiogram, an ultrasound scan that shows the heart’s structure and how well it is pumping. This helps confirm whether the heart muscle and valves are normal. Depending on the situation, blood tests or a period of heart rhythm monitoring may also be suggested.

The point of these tests is not the block itself, which generally cannot and need not be reversed. It is to make sure there is nothing else going on that the RBBB might be pointing to.

When RBBB Sits Alongside Other Findings

One situation deserves a mention because it changes the picture. Sometimes RBBB appears on an ECG together with other conduction delays. When the heart’s electrical pathways show several areas of slowing at once, cardiologists pay closer attention, because the wiring is showing wear in more than one place.

In a small number of people, particularly those who also have symptoms such as fainting, this combination may eventually lead to a conversation about a pacemaker. This is the exception rather than the rule, and it applies to a minority of cases. The great majority of people with a simple, isolated RBBB never approach this territory.

Heart Matters Resource

When in Doubt, Get Checked Out

A new finding on an ECG, or one that comes with chest pain, breathlessness, or fainting, is always worth discussing promptly with your GP or cardiologist rather than worrying about alone.

Read: When in Doubt, Get Checked Out →

Conclusion

A right bundle branch block is an electrical finding, not a blocked artery, and for most people who carry one it is a harmless quirk of their heart’s wiring that will never cause a problem. The word block makes it sound far more alarming than it usually is.

What turns a routine finding into one worth investigating is context: whether it is new, whether it comes with symptoms, and whether it sits alongside other changes. If your ECG shows a right bundle branch block and you feel well, the most likely explanation is the most reassuring one. If it is new or you have symptoms, it is worth discussing with your cardiologist promptly, who can place that single line on the report into the bigger picture of your heart.

The Echocardiogram: What It Shows and Why It Matters

June 12, 2026June 12, 2026

The echocardiogram is cardiology’s most comprehensive non-invasive imaging test. Here is what it reveals about your heart and what to expect from the procedure.

CT Coronary Angiogram (CTCA): What It Is, What to Expect, and What It Shows

May 31, 2026May 11, 2026

The CT coronary angiogram gives a detailed view of the coronary arteries without any catheters, just a scan and a cannula. Here is what to expect from the procedure and how to interpret the results.

What Is a BNP Test? Understanding This Key Heart Failure Blood Test

May 31, 2026April 20, 2026

Key Points

BNP and NT-proBNP are blood markers released by the heart when it is under increased strain, and are the primary blood tests used to diagnose and monitor heart failure.
Elevated levels indicate that the heart is working harder than it should, but the result must always be interpreted in clinical context alongside symptoms, examination, and other investigations.
A normal BNP or NT-proBNP result in someone with breathlessness is genuinely reassuring. It makes significant heart failure unlikely and helps direct the investigation toward other causes.
Levels are used not only for diagnosis but to guide treatment intensity and monitor response. Falling levels generally indicate that treatment is working.
Several non-cardiac conditions can elevate BNP and NT-proBNP, including kidney disease, pulmonary embolism, and atrial fibrillation. The result is a clinical signal, not a standalone diagnosis.

Breathlessness is one of the most common and diagnostically challenging symptoms in medicine. It can come from the heart, the lungs, anaemia, deconditioning, anxiety, or a combination of several factors, and distinguishing between them on clinical grounds alone is often difficult.

BNP and NT-proBNP are blood tests that provide a direct signal from the heart itself. When the heart is under strain, pumping against increased pressure or struggling to maintain adequate output, it releases these proteins into the bloodstream. Measuring them gives the clinical team an objective window into how hard the heart is working.

Understanding what this test measures, what an elevated result means, and crucially what a normal result tells you makes a real difference to how patients engage with their diagnosis and their treatment.

What Are BNP and NT-proBNP?

Where They Come From

BNP stands for B-type natriuretic peptide, a protein produced by the muscle cells of the heart’s ventricles (the main pumping chambers) in response to increased wall stress. When the ventricles are stretched or under increased pressure, as they are in heart failure, they release this protein into the bloodstream as a distress signal.

Different laboratories and hospitals may measure either BNP or NT-proBNP depending on their equipment. The two tests are not interchangeable in terms of their numerical values, but both give equivalent clinical information when read with the appropriate reference ranges.

How BNP is produced

Heart under strain

The pumping chambers of the heart are stretched or under increased pressure, as in heart failure.

Protein released

Heart muscle cells release a stress protein into the bloodstream as a signal that the heart is struggling.

Two fragments released

The protein splits into two measurable fragments, BNP and NT-proBNP. Either can be tested in a blood sample.

Measured and interpreted

Higher levels mean more strain on the heart. Your doctor uses this number to help diagnose and monitor heart failure.

Important Note

NT-proBNP has a longer half-life than BNP and tends to produce higher numerical values. The two tests are not interchangeable. Always compare results using the same assay over time.

What Elevated Levels Mean

High BNP or NT-proBNP levels tell the clinical team that the heart is under increased mechanical stress. The ventricles are stretched, the pressures within the heart are elevated, or the heart is compensating for reduced pump function. This is the physiological hallmark of heart failure.

The higher the level, the greater the degree of cardiac stress and generally the more severe the heart failure. But the number must always be interpreted alongside the full clinical picture.

What to Expect

What to Expect: BNP / NT-proBNP Blood Test

Duration

A standard blood draw taking around 5 minutes. Results are typically available within 1-2 hours in hospital, or a few days in an outpatient setting.

Preparation

No fasting required. Can be taken at any time and is often collected alongside kidney function, troponin, and a full blood count.

Comfort

Standard blood draw from a vein in the arm. No discomfort beyond the needle itself.

Radiation / Contrast

None whatsoever.

Results

Must always be read alongside symptoms, examination, and other tests. A single number in isolation is not a diagnosis.

Monitoring over time

In known heart failure, levels are measured repeatedly over time. Falling levels indicate improvement. Rising levels may suggest the condition is worsening.

How the Result Is Used

Diagnosing Heart Failure

In a patient presenting with breathlessness, the BNP or NT-proBNP level is one of the most clinically useful initial tests available. A markedly elevated result in someone with typical symptoms strongly supports a diagnosis of heart failure and typically leads to echocardiography to assess cardiac structure and ejection fraction (a measure of how well the heart is pumping).

Critically, a normal result is equally valuable. In someone presenting with breathlessness, a low BNP or NT-proBNP makes significant heart failure very unlikely and redirects the investigation toward lung, blood-related, or other causes. This is one of the most efficient and reassuring pieces of information the test can provide.

Monitoring Treatment

Once heart failure is diagnosed and treatment is initiated, BNP and NT-proBNP levels are measured repeatedly over time. Falling levels generally indicate that the heart is responding to treatment, as the pressure and stretch on the ventricular walls is reducing. Rising levels, conversely, may signal that the heart failure is worsening or that the patient is not responding adequately to their current regimen.

Many cardiologists use BNP-guided therapy, adjusting medications based not just on symptoms but on the trajectory of the BNP level over time. This approach helps identify deterioration before it becomes clinically apparent.

Guiding Discharge and Predicting Outcomes

In hospitalised patients with acute heart failure, BNP levels at discharge help predict the risk of early readmission. Patients discharged with persistently high levels are at higher risk of returning to hospital and may benefit from closer early follow-up.

BNP is one of the most useful tests in heart failure management, not as a single snapshot, but as a trend over time. A patient whose NT-proBNP has halved over three months of optimised treatment is doing well, regardless of how they feel on any given day. The number often tells you what is happening before the patient notices the change themselves.

A/Prof. Nagesh Anavekar, Cardiologist

Other Causes of Elevated BNP

Kidneys

Kidney disease

Impaired kidney function reduces BNP clearance, producing persistently elevated levels that do not reflect an actual worsening of heart function.

Lungs

Pulmonary embolism

A large blood clot in the lungs puts sudden strain on the right side of the heart, triggering BNP release as a stress signal.

Heart Rhythm

Atrial fibrillation

AF causes mild BNP elevation due to the stretching of the upper heart chambers and the effects of an irregular heart rate on blood flow.

Blood Pressure

High blood pressure

Longstanding high blood pressure increases the workload on the heart, which can modestly elevate BNP even before heart failure develops.

Age

Getting older

BNP and NT-proBNP levels naturally rise with age. Doctors use age-adjusted reference ranges to interpret results correctly.

Serious Illness

Sepsis and critical illness

Severe illness throughout the body can put stress on the heart and raise BNP levels, even when heart failure is not the underlying cause.

One counter-intuitive but clinically important finding is that BNP levels tend to be lower in obese patients, even those with significant heart failure. The reason is not entirely understood but relates partly to increased BNP clearance by fat tissue. This means that in an obese patient with breathlessness, a BNP level that would be reassuring in someone of normal weight requires more careful interpretation.

Your cardiologist will take this into account. It is one of the reasons clinical context always accompanies the number.

Questions Worth Asking About Your BNP Result

Is my BNP or NT-proBNP result elevated, and if so, by how much?
Does a normal result mean my breathlessness is definitely not from heart failure?
I have kidney disease. Does that affect the interpretation of my result?
Should I have a repeat measurement in a few months to monitor the trend?
What other investigations are being arranged alongside this test?

Heart Matters Resource

Your Heart Toolkit includes downloadable guides, checklists, and resources to help you understand your heart health, including tools for tracking results and preparing for appointments.

Explore Your Heart Toolkit

Heart Matters Resource

When in Doubt, Get Checked Out

Breathlessness that is new, worsening, or occurring at rest deserves prompt medical assessment. A BNP or NT-proBNP test is often one of the first and most informative steps, and a normal result is genuinely reassuring.

Read: When in Doubt, Get Checked Out

Conclusion

BNP and NT-proBNP are among the most clinically useful blood tests in cardiology, providing a direct signal from the heart about how hard it is working. An elevated result points toward heart failure and triggers further investigation. A normal result in someone with breathlessness is one of the most efficient pieces of reassurance available, making significant heart failure unlikely and redirecting the investigation efficiently.

Used over time, the trajectory of BNP levels tells the clinical story of heart failure management, whether treatment is working, whether the heart is improving, and when closer attention is needed. It is a test that keeps giving information long after the initial diagnosis is made.

If you have had this test and are trying to make sense of your result, bring the number to your next appointment and ask what it means in the context of your full clinical picture.

This article provides general information only and is not medical advice. Any decisions about your tests or treatment should be made in conversation with your cardiologist or GP.

The hs-CRP Test: Inflammation, Heart Risk, and Why Context Matters

April 18, 2026April 16, 2026

Blood test tube labelled hs-CRP Test held by a gloved hand in a laboratory

The hs-CRP test measures inflammation in the blood — but it is not a diagnostic test for heart disease. Here is what it can and cannot tell us about cardiovascular risk.

Tests & Procedures

Left Ventricular Hypertrophy (LVH) on Your ECG

The Stress Echocardiogram: What to Expect

ApoB Explained: What It Measures and Why LDL Still Matters

What Is a Troponin Test, and Why Is It Used for Chest Pain?

Right Bundle Branch Block (RBBB): Why It Sounds Worse Than It Usually Is

The Echocardiogram: What It Shows and Why It Matters

CT Coronary Angiogram (CTCA): What It Is, What to Expect, and What It Shows

What Is a BNP Test? Understanding This Key Heart Failure Blood Test

The hs-CRP Test: Inflammation, Heart Risk, and Why Context Matters

Lipoprotein(a): The Inherited Heart Risk Most People Have Never Heard Of

Leadless Pacemakers: A New Era in Cardiac Pacing

Drug-Coated Balloons: A New Frontier in Treating Coronary Artery Disease

First-Degree AV Block on Your ECG: What Does It Really Mean?

Transoesophageal Echocardiogram (TOE/TEE): What It Is and What to Expect

The Electrocardiogram (ECG / EKG)

Recovering After a Coronary Angiogram: What to Expect

The Coronary Calcium Score: What It Measures and What to Expect

What the Left Ventricle Does and Why It Thickens

What the ECG Can and Cannot Tell You

What the Report Might Say

What Causes Genuine Thickening

What Happens Next

Why It Is Worth Knowing About

Conclusion

Related Reading

What Is ApoB, Exactly?

Why Counting Particles Can Beat Measuring Cholesterol

The family of particles apoB counts

When LDL Cholesterol and ApoB Disagree

Who is most likely to be discordant

What the Evidence Actually Shows

Why LDL, Triglycerides, and Lp(a) Still Matter

LDL cholesterol

Triglycerides

Lipoprotein(a)

What Does a Statin Do to Your ApoB?

ApoB Is One Piece of a Multifactorial Picture

The Role of Investigations

Where the Guidelines Stand

Should You Add ApoB to Your Next Blood Test?

When in Doubt, Get Checked Out

Conclusion

Related Reading

What the Bundle Branches Actually Do

What RBBB Looks Like on an ECG, in Plain Language

Why Does a Right Bundle Branch Block Happen?

The Question That Really Matters: Is It New?

RBBB and LBBB Are Not the Same Story

Will I Have Symptoms?

What Happens Next, and What Tests Might Be Done

When RBBB Sits Alongside Other Findings

When in Doubt, Get Checked Out

Conclusion

Related Reading

Key Points

What Are BNP and NT-proBNP?

Where They Come From

What Elevated Levels Mean

What to Expect

How the Result Is Used

Diagnosing Heart Failure

Monitoring Treatment

Guiding Discharge and Predicting Outcomes

Other Causes of Elevated BNP

Questions Worth Asking About Your BNP Result

When in Doubt, Get Checked Out

Conclusion

Related Reading

Stay Informed